BACKGROUND: Multiple systematic reviews examine the introduction of foods in relation to individual health outcomes, but the balance of harms and benefits has not been overviewed systematically. OBJECTIVES: We aimed to perform an overview of systematic reviews on age of introduction of complementary and allergenic foods to the infant diet and long and short-term health outcomes. DATA SOURCES: We searched Medline, Embase, Cochrane, and PubMed (July 25, 2022). STUDY SELECTION: Included systematic reviews examining the introduction of complementary or allergenic foods before age 1. Outcomes included allergic, autoimmune, and inflammatory diseases, neurodevelopment, nutrition, and weight. DATA EXTRACTION: Extraction and quality assessment were performed in duplicate (A Measurement Tool to Assess Systematic Reviews) and strength of evidence was assessed. RESULTS: We screened 4015 articles and included 32 systematic reviews. There was moderate evidence that peanut and egg should be introduced from 4 to 11 months to prevent food allergy (6 of 10 reviews). Complementary food introduction was not associated with food allergy. Moderate certainty evidence suggested age of complementary food introduction was not associated with eczema. Age at introduction of gluten was not associated with celiac disease (high certainty evidence; 3 of 4 reviews). Low certainty evidence indicated that introducing solids before 4 months may increase the risk of childhood obesity, but not growth. There was insufficient evidence regarding an association between any food introduction and bone health, gastrointestinal diseases, autoimmune disorders, asthma, or allergic rhinitis. LIMITATIONS: Gray literature was not included. CONCLUSIONS: Current evidence supports introducing complementary foods around 6 months and allergenic foods before 11 months.
Background/ObjectivesEczema is a common chronic debilitating skin condition in childhood. Data on the epidemiology and natural history of eczema across the life course are lacking. This analysis aimed to describe these epidemiological features in Australian children and adults. MethodsData collected on eczema from four Australian cohort studies were analysed: namely HealthNuts, Melbourne Atopic Cohort Study (MACS), Tasmanian Longitudinal Health Study (TAHS) and the Australian arm of the European Community Respiratory Health Survey (ECRHS). ResultsAmong children aged under 6 years, 28.8%-35.6% have ever-had eczema, and 16.7%-26.6% had 'current eczema'. Among those aged 6-12 years, 14.6%-24.7% had 'current eczema' with 12.0%-18.5% of those at ages of 6 and 10 years classified as having moderate-to-severe eczema according to the Scoring of Atopic Dermatitis (SCORAD) index. In adults, the prevalence of 'eczema ever' ranged between 13.8% and 48.4%. The 12-month period prevalence of eczema was 15.1% at age 18, while current eczema was 8.5% at an average age of 51, and 8.8% at an average age 53 years. Eczema was more common among young boys, but this difference became non-significant for older children and early adolescents. In contrast, eczema was more common for adult women than men. ConclusionsEczema is common both in children and adults. The proportion of severe eczema in children was substantial.
Background: Food allergy algorithms provide a systematic approach to assigning food allergy outcomes in research studies when oral food challenges (OFC) are not performed. Currently no such algorithms validated for infants exist. We aimed to develop and validate a research algorithm for classifying infant food allergies. Methods: An algorithm incorporating skin prick test (SPT), allergen ingestion, and reaction data was developed and validated by comparing peanut, cashew, egg, and cow's milk algorithm outcomes to OFC outcomes in infants from the Vitality ( n = 285) (NCT02112734), EarlyNuts ( n = 111) (ACTRN12618001990213), and HealthNuts ( n = 191) studies. Results: Validation included 740 OFCs from 587 infants (191 SPT‐negative [0 mm] and 396 SPT‐positive [≥1 mm] infants; first‐OFC median age: 14.4 months). The algorithm assigned all SPT‐negative infants as tolerant, achieving 99.5% agreement with OFCs (peanut 100% [ n = 135/135]; egg 98.2% [ n = 55/56]). The algorithm assigned an allergic or tolerant outcome to 65% (93/144) of peanut SPT‐positive, 38% (41/108) cashew SPT‐positive, 81% ( n = 209/258) egg SPT‐positive, and 90% ( n = 35/39) milk SPT‐positive infants. Agreement with OFC was 81% ( n = 75/93) for peanut, 88% ( n = 36/41) for cashew, 88% ( n = 184/209) for egg, and 97% ( n = 34/35) for milk. Accuracy and areas under the curve (AUCs) were fair‐to‐excellent: peanut (AUC = 0.79 [95% confidence interval [CI]: 0.71–0.88]; sensitivity = 87% [95% CI: 75–95]; specificity = 72% [95% CI: 55–85]), cashew (AUC = 0.88 [95% CI: 0.77–0.98]; sensitivity = 84% [95% CI: 60–97]; specificity = 91% [95% CI: 71–99]); egg (AUC = 0.88 [95% CI: 0.81–0.94]; sensitivity = 88% [95% CI: 83–93]; specificity = 87% [95% CI: 70–96]); milk (AUC = 0.98 [95% CI: 0.94–1]; sensitivity = 96% [95% CI: 80–100]; specificity = 100% [95% CI: 69–100]). Conclusion: Using routinely collected data, this validated infant‐focused food allergy algorithm performed well in classifying peanut, cashew, egg, and cow's milk allergies, offering applicability in research settings. image